Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 108 | 498 | 11,023 | 15,034 | 13,903 |
| Cost of Goods | N/A | N/A | 8,160 | 11,418 | 11,694 |
| Gross Profit | 108 | 498 | 2,863 | 3,616 | 2,209 |
| Operating Expenses | 10,162 | 3,576 | 8,442 | 6,661 | 2,491 |
| Operating Income | -10,054 | -3,078 | -5,419 | -2,627 | 412 |
| Interest Expense | 69 | 18 | 82 | 37 | 3 |
| Other Income | -335 | 494 | 7 | 462 | 5 |
| Pre-tax Income | -10,458 | -2,602 | -5,494 | -2,202 | 413 |
| Income Tax | -2 | -1 | 813 | -1,071 | N/A |
| Net Income Continuous | -10,460 | -2,603 | -6,306 | -1,131 | 413 |
| Net Income Discontinuous | N/A | N/A | -11,448 | N/A | N/A |
| Net Income | $-10,460 | $-2,603 | $-17,754 | $-1,131 | $413 |
| EPS Basic Total Ops | -1.60 | -0.81 | -30.09 | -2.70 | 1.20 |
| EPS Basic Continuous Ops | -1.60 | -0.81 | -10.68 | -2.70 | 1.11 |
| EPS Basic Discontinuous Ops | N/A | N/A | -19.41 | N/A | N/A |
| EPS Diluted Total Ops | -1.60 | -0.81 | -30.09 | -2.70 | 0.90 |
| EPS Diluted Continuous Ops | -1.60 | -0.81 | -10.68 | -2.70 | 1.03 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -19.41 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.60 | -2.61 | -29.40 | -2.70 | 0.90 |
| EBITDA(a) | $-9,113 | $-3,078 | $-5,199 | $-2,391 | $424 |